FMNL1 promotes proliferation and migration of leukemia cells (2013)
- Autores:
- Autor USP: TRAINA, FABÍOLA - FMRP
- Unidade: FMRP
- DOI: 10.1189/jlb.0113057
- Assuntos: LEUCEMIA; APOPTOSE; PROLIFERAÇÃO CELULAR
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título do periódico: Journal of Leukocyte Biology
- ISSN: 0741-5400
- Volume/Número/Paginação/Ano: v. 94, n. 3, p. 503-512, 2013
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
FAVARO, Patricia et al. FMNL1 promotes proliferation and migration of leukemia cells. Journal of Leukocyte Biology, v. 94, n. 3, p. 503-512, 2013Tradução . . Disponível em: https://doi.org/10.1189/jlb.0113057. Acesso em: 16 abr. 2024. -
APA
Favaro, P., Traina, F., Machado Neto, J. A., Lazarini, M., Lopes, M. R., Pereira, J. K. N., et al. (2013). FMNL1 promotes proliferation and migration of leukemia cells. Journal of Leukocyte Biology, 94( 3), 503-512. doi:10.1189/jlb.0113057 -
NLM
Favaro P, Traina F, Machado Neto JA, Lazarini M, Lopes MR, Pereira JKN, Costa FF, Infante E, Ridley AJ, Saad STO. FMNL1 promotes proliferation and migration of leukemia cells [Internet]. Journal of Leukocyte Biology. 2013 ; 94( 3): 503-512.[citado 2024 abr. 16 ] Available from: https://doi.org/10.1189/jlb.0113057 -
Vancouver
Favaro P, Traina F, Machado Neto JA, Lazarini M, Lopes MR, Pereira JKN, Costa FF, Infante E, Ridley AJ, Saad STO. FMNL1 promotes proliferation and migration of leukemia cells [Internet]. Journal of Leukocyte Biology. 2013 ; 94( 3): 503-512.[citado 2024 abr. 16 ] Available from: https://doi.org/10.1189/jlb.0113057 - FMNL1 is downregulated in myelodysplastic syndromes and is involved in megakaryocytic differentiation
- Increased inflammatory markers and their correlations to clinical complications in hemoglobin SC disease
- YAP1 expression in myelodysplastic syndromes and acute leukemias. [Carta]
- ANKHD1, a novel component of the Hippo signaling pathway, promotes YAP1 activation and cell cycle progression in prostate cancer cells
- Differential profile of PIP4K2A expression in hematological malignancies
- Abnormal Hedgehog pathway in myelodysplastic syndrome and its impact on patients' outcome. [Carta]
- Key endothelial cell angiogenic mechanisms are stimulated by the circulating milieu in sickle cell disease and attenuated by hydroxyurea
- IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms
- Padronização da investigação laboratorial de anticorpos dirigidos contra fármacos em doadores de sangue e pacientes com anemia hemolítica imune
- Hydroxyurea therapy reduces the hypercoagulability state in a sickle cell mouse model
Informações sobre o DOI: 10.1189/jlb.0113057 (Fonte: oaDOI API)
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
